Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fexofenadine for Ureteral Stent-Related Symptoms
NCT04726345Phase 2Completed
- Sponsor
- Columbia University
- Start
- Jun 2021
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fexofenadine in ureteral stent-related symptoms (USRS), sponsored by Columbia University. Started Jun 2021; status: completed.
02
Drugs
fexofenadine
03
Conditions
ureteral stent-related symptoms (USRS)
Beyond the preview
Go deeper on NCT04726345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04726345.